51.74
-1.33
(-2.51%)
At close: January 30 at 4:00:00 PM EST
51.75
+0.01
+(0.02%)
After hours: January 30 at 5:22:07 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-100,180.00
-117,493.00
-49,030.00
3,748.00
-21,138.00
Investing Cash Flow
-121,771.00
140,604.00
-144,629.00
-586.00
-456.00
Financing Cash Flow
171,489.00
130,176.00
93,987.00
21.00
131,771.00
End Cash Position
176,210.00
224,947.00
71,660.00
171,332.00
168,149.00
Interest Paid Supplemental Data
6,334.00
2,880.00
1,675.00
--
--
Capital Expenditure
-1,495.00
-5,502.00
-506.00
-586.00
-456.00
Issuance of Capital Stock
117,509.00
118,599.00
74,352.00
--
131,401.00
Issuance of Debt
75,000.00
10,000.00
20,000.00
--
--
Repurchase of Capital Stock
--
--
--
--
-28.00
Free Cash Flow
-101,675.00
-122,995.00
-49,536.00
3,162.00
-21,594.00
12/31/2020 - 10/16/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SWTX SpringWorks Therapeutics, Inc.
37.23
+1.94%
VERA Vera Therapeutics, Inc.
37.48
-1.19%
RNA Avidity Biosciences, Inc.
32.63
+2.22%
JANX Janux Therapeutics, Inc.
44.79
+5.36%
VRNA Verona Pharma plc
57.24
+4.40%
SRRK Scholar Rock Holding Corporation
40.40
-5.08%
BPMC Blueprint Medicines Corporation
114.05
-0.24%
MIRM Mirum Pharmaceuticals, Inc.
48.44
-0.33%
EWTX Edgewise Therapeutics, Inc.
28.00
-1.48%
NUVL Nuvalent, Inc.
87.75
+2.61%